ECT 2 amplification and overexpression as a new prognostic biomarker for early‐stage lung adenocarcinoma

Author:

Murata Yoshihiko1,Minami Yuko2,Iwakawa Reika3,Yokota Jun3,Usui Shingo1,Tsuta Koji4,Shiraishi Kouya3,Sakashita Shingo2,Satomi Kaishi2,Iijima Tatsuo5,Noguchi Masayuki2

Affiliation:

1. Department of Pathology Graduate School of Comprehensive Human Sciences University of Tsukuba Ibaraki Japan

2. Department of Pathology Faculty of Medicine University of Tsukuba Ibaraki Japan

3. Division of Genome Biology National Cancer Center Research Institute Tokyo Japan

4. Pathology Division National Cancer Center Research Institute TokyoJapan

5. Department of Pathology Ibaraki Prefectural Central Hospital Ibaraki Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference43 articles.

1. Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer

2. K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung

3. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis;Greenblatt MS;Cancer Res,1994

4. BRAF and RAS mutations in human lung cancer and melanoma;Brose MS;Cancer Res,2002

5. Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3